Viatris Ownership

VTRS Stock  USD 9.35  0.02  0.21%   
Viatris shows a total of 1.17 Billion outstanding shares. The majority of Viatris outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Viatris to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Viatris. Please pay attention to any change in the institutional holdings of Viatris as this could imply that something significant has changed or is about to change at the company. On May 15, 2025, Senator John Fetterman of US Senate acquired under $15k worth of Viatris's common stock.
 
Shares in Circulation  
First Issued
1985-09-30
Previous Quarter
1.2 B
Current Value
1.2 B
Avarage Shares Outstanding
430.7 M
Quarterly Volatility
288.1 M
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Viatris. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Viatris Stock please use our How to Invest in Viatris guide.

Viatris Stock Ownership Analysis

About 85.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 0.69. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Viatris has Price/Earnings To Growth (PEG) ratio of 0.15. The entity recorded a loss per share of 3.18. The firm last dividend was issued on the 23rd of May 2025. Viatris had 3:2 split on the 9th of October 2003. The company operates in four segments Developed Markets, Greater China, JANZ, and Emerging Markets. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania. Viatris operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 37000 people. For more information please call Scott Smith at 724 514 1800 or visit https://www.viatris.com.
Besides selling stocks to institutional investors, Viatris also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Viatris' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Viatris' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Viatris Quarterly Liabilities And Stockholders Equity

38.47 Billion

Viatris Insider Trades History

Less than 1% of Viatris are currently held by insiders. Unlike Viatris' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Viatris' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Viatris' insider trades
 
Covid

Viatris Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Viatris is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Viatris backward and forwards among themselves. Viatris' institutional investor refers to the entity that pools money to purchase Viatris' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Charles Schwab Investment Management Inc2025-03-31
12.1 M
Northern Trust Corp2025-03-31
12.1 M
Australiansuper Pty Ltd2025-03-31
11.6 M
Norges Bank2024-12-31
11.5 M
Pacer Advisors, Inc.2025-03-31
11.4 M
Bank Of New York Mellon Corp2025-03-31
10.4 M
Deutsche Bank Ag2025-03-31
10.1 M
Bank Of America Corp2025-03-31
9.5 M
Legal & General Group Plc2025-03-31
8.6 M
Vanguard Group Inc2025-03-31
144.6 M
Blackrock Inc2025-03-31
97 M
Note, although Viatris' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Viatris Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Viatris insiders, such as employees or executives, is commonly permitted as long as it does not rely on Viatris' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Viatris insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Viatris' latest congressional trading

Congressional trading in companies like Viatris, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Viatris by those in governmental positions are based on the same information available to the general public.
2025-05-15Senator John FettermanAcquired Under $15KVerify
2025-04-08Representative Gilbert CisnerosAcquired Under $15KVerify
2022-09-15Senator Tommy TubervilleAcquired Under $15KVerify
2021-01-26Representative Mo BrooksAcquired Under $15KVerify
2020-12-01Representative Debbie DingellAcquired Under $15KVerify

Viatris Outstanding Bonds

Viatris issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Viatris uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Viatris bonds can be classified according to their maturity, which is the date when Viatris has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Viatris Corporate Filings

14th of May 2025
Other Reports
ViewVerify
F3
13th of May 2025
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
8K
8th of May 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
10K
30th of April 2025
An amendment to a previously filed Form 10-K
ViewVerify

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Viatris Stock Analysis

When running Viatris' price analysis, check to measure Viatris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viatris is operating at the current time. Most of Viatris' value examination focuses on studying past and present price action to predict the probability of Viatris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viatris' price. Additionally, you may evaluate how the addition of Viatris to your portfolios can decrease your overall portfolio volatility.